Here we derive the differential equations governing the per cell quota of CRISPR spacer contents.
proportional to the removal rate of infected cells and is equal to . For any small time interval then , we can write as:
, where the denominator is the expected infected cell density at time . Thus is precisely the average protospacer content per infected cell at time . In a straightforward fashion, when ≠ 0, we can compute the limit to obtain our derivative:
We now follow a similar procedure to compute the average spacer contents in the free and infected cell populations.
CRISPR Spacer Quota Per infected Cell We derive the derivatives for the per capita quotas of CRISPR spacer content using the same approach as above. Briefly, new additions to the active and self-targeting spacer content associated with infected cell population can occur upon infection due to acquisition reactions. In addition, they are also inherited from free cells that are infected. Inactive spacers in the infected cell population, however, can only be inherited. Furthermore, we will also account for the removal of spacers due to CRISPR kinetics through a spacer deletion parameter .
Given the current phage protospacer levels available per infected cell ( ) for spacer acquisitions and the acquisition rate of , the total amount of new active spacer acquisitions is computed as . Similarly, given the current genomic protospacer density of , the total amount of newly acquired self-targeting spacer content is given by . For a given spacer type, the total inflow due to inheritance is determined by the amount of infections ( ) and the spacer density of that type in the free cell population (e.g., for active spacers). Finally, all three spacer types within an infected cell are also removed at a rate proportional to the removal rate of infected cells and spacer deletion. Taken together this results in the following equations for the different spacer contents at time :
, Computing , , and , for ≠ 0, we obtain the corresponding derivatives as: 
